Inspire Medical Systems, Inc. Financing Cash Flow
Inspire Medical Systems, Inc. (INSP) reported Financing Cash Flow of -$5.57 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-03
- Inspire Medical Systems, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $1.91M, a 48.31% decline year-over-year.
- Inspire Medical Systems, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was -$7.48M.
- Inspire Medical Systems, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was -$48.31M.
- Inspire Medical Systems, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was -$51.08M, a 616.46% decline year-over-year.
- Inspire Medical Systems, Inc. net cash provided by (used in) financing activities for fiscal 2025 was -$183.45M.
- Inspire Medical Systems, Inc. net cash provided by (used in) financing activities for fiscal 2024 was -$52.39M, a 475.58% decline from fiscal 2023.
- Inspire Medical Systems, Inc. net cash provided by (used in) financing activities for fiscal 2023 was $13.95M, a 94.07% decline from fiscal 2022.
- Inspire Medical Systems, Inc. net cash provided by (used in) financing activities for fiscal 2022 was $235.08M, a 1472.63% increase from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | -$5.57M 10-Q · filed 2026-08-03 | -$53.88M derived: sum of 3 quarters · filed 2026-08-03 | -$104.96M derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | -$7.48M 10-Q · filed 2026-05-04 | -$55.79M derived: sum of 2 quarters · filed 2026-05-04 | -$106.87M derived: sum of 3 quarters · filed 2026-05-04 | -$103.17M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | -$48.31M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | -$99.39M derived: sum of 2 quarters · filed 2026-02-13 | -$95.69M derived: sum of 3 quarters · filed 2026-08-03 | -$183.45M 10-K · filed 2026-02-13 |
| 2025-09-30 | -$51.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | -$47.38M derived: sum of 2 quarters · filed 2026-08-03 | -$135.14M 10-Q · filed 2025-11-03 | -$205.28M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | $3.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | -$84.06M 10-Q · filed 2026-08-03 | -$154.20M derived: sum of 3 quarters · filed 2026-08-03 | -$144.31M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | -$87.76M 10-Q · filed 2026-05-04 | -$157.90M derived: sum of 2 quarters · filed 2026-05-04 | -$148.01M derived: sum of 3 quarters · filed 2026-05-04 | -$140.92M derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | -$70.14M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | -$60.25M derived: sum of 2 quarters · filed 2026-02-13 | -$53.16M derived: sum of 3 quarters · filed 2026-02-13 | -$52.39M 10-K · filed 2026-02-13 |
| 2024-09-30 | $9.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $16.98M derived: sum of 2 quarters · filed 2025-11-03 | $17.75M 10-Q · filed 2025-11-03 | $7.63M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-06-30 | $7.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | $7.86M 10-Q · filed 2025-08-04 | -$2.26M derived: sum of 3 quarters · filed 2026-02-13 | $1.24M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-03-31 | $768.00K 10-Q · filed 2025-05-05 | -$9.35M derived: sum of 2 quarters · filed 2026-02-13 | -$5.85M derived: sum of 3 quarters · filed 2026-02-13 | $9.09M derived: sum of 4 quarters · filed 2026-02-13 |
| 2023-12-31 | -$10.12M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | -$6.62M derived: sum of 2 quarters · filed 2026-02-13 | $8.32M derived: sum of 3 quarters · filed 2026-02-13 | $13.95M 10-K · filed 2026-02-13 |
| 2023-09-30 | $3.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | $18.43M derived: sum of 2 quarters · filed 2024-11-04 | $24.07M 10-Q · filed 2024-11-04 | $31.35M derived: sum of 4 quarters · filed 2025-02-10 |
| 2023-06-30 | $14.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $20.57M 10-Q · filed 2024-08-06 | $27.85M derived: sum of 3 quarters · filed 2025-02-10 | $251.98M derived: sum of 4 quarters · filed 2025-02-10 |
| 2023-03-31 | $5.63M 10-Q · filed 2024-05-07 | $12.92M derived: sum of 2 quarters · filed 2025-02-10 | $237.04M derived: sum of 3 quarters · filed 2025-02-10 | $237.66M derived: sum of 4 quarters · filed 2025-02-10 |
| 2022-12-31 | $7.29M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-10 | $231.41M derived: sum of 2 quarters · filed 2025-02-10 | $232.03M derived: sum of 3 quarters · filed 2025-02-10 | $235.08M 10-K · filed 2025-02-10 |
| 2022-09-30 | $224.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $224.74M derived: sum of 2 quarters · filed 2023-11-07 | $227.79M 10-Q · filed 2023-11-07 | $231.86M derived: sum of 4 quarters · filed 2024-02-09 |
| 2022-06-30 | $619.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | $3.66M 10-Q · filed 2023-08-01 | $7.74M derived: sum of 3 quarters · filed 2024-02-09 | $11.58M derived: sum of 4 quarters · filed 2024-02-09 |
| 2022-03-31 | $3.04M 10-Q · filed 2023-05-02 | $7.12M derived: sum of 2 quarters · filed 2024-02-09 | $10.96M derived: sum of 3 quarters · filed 2024-02-09 | $14.44M derived: sum of 4 quarters · filed 2024-02-09 |
| 2021-12-31 | $4.08M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-09 | $7.92M derived: sum of 2 quarters · filed 2024-02-09 | $11.40M derived: sum of 3 quarters · filed 2024-02-09 | $14.95M 10-K · filed 2024-02-09 |
| 2021-09-30 | $3.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | $7.32M derived: sum of 2 quarters · filed 2022-11-01 | $10.87M 10-Q · filed 2022-11-01 | $15.39M derived: sum of 4 quarters · filed 2023-02-10 |
| 2021-06-30 | $3.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $7.03M 10-Q · filed 2022-08-02 | $11.55M derived: sum of 3 quarters · filed 2023-02-10 | $13.86M derived: sum of 4 quarters · filed 2023-02-10 |
| 2021-03-31 | $3.55M 10-Q · filed 2022-05-03 | $8.07M derived: sum of 2 quarters · filed 2023-02-10 | $10.38M derived: sum of 3 quarters · filed 2023-02-10 | $136.83M derived: sum of 4 quarters · filed 2023-02-10 |
| 2020-12-31 | $4.52M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | $6.83M derived: sum of 2 quarters · filed 2023-02-10 | $133.28M derived: sum of 3 quarters · filed 2023-02-10 | $134.06M 10-K · filed 2023-02-10 |
| 2020-09-30 | $2.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $128.76M derived: sum of 2 quarters · filed 2021-11-02 | $129.54M 10-Q · filed 2021-11-02 | $130.44M derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-06-30 | $126.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $127.23M 10-Q · filed 2021-08-03 | $128.13M derived: sum of 3 quarters · filed 2022-02-15 | $128.32M derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-03-31 | $787.00K 10-Q · filed 2021-05-04 | $1.68M derived: sum of 2 quarters · filed 2022-02-15 | $1.88M derived: sum of 3 quarters · filed 2022-02-15 | $3.12M derived: sum of 4 quarters · filed 2022-02-15 |
| 2019-12-31 | $897.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | $1.09M derived: sum of 2 quarters · filed 2022-02-15 | $2.33M derived: sum of 3 quarters · filed 2022-02-15 | $1.96M 10-K · filed 2022-02-15 |
| 2019-09-30 | $192.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02 | $1.43M derived: sum of 2 quarters · filed 2020-11-02 | $1.07M 10-Q · filed 2020-11-02 | $70.98M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-30 | $1.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $875.00K 10-Q · filed 2020-08-04 | $70.78M derived: sum of 3 quarters · filed 2021-02-24 | $70.83M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-31 | -$366.00K 10-Q · filed 2020-05-05 | $69.54M derived: sum of 2 quarters · filed 2021-02-24 | $69.59M derived: sum of 3 quarters · filed 2021-02-24 | $181.83M derived: sum of 4 quarters · filed 2021-02-24 |
| 2018-12-31 | $69.91M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $69.96M derived: sum of 2 quarters · filed 2021-02-24 | $182.20M derived: sum of 3 quarters · filed 2021-02-24 | $190.38M 10-K · filed 2021-02-24 |
| 2018-09-30 | $46.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $112.29M derived: sum of 2 quarters · filed 2019-11-05 | $120.47M 10-Q · filed 2019-11-05 | $120.61M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | $112.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $120.43M 10-Q · filed 2019-08-06 | $120.57M derived: sum of 3 quarters · filed 2020-02-25 | $120.65M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | $8.19M 10-Q · filed 2019-05-07 | $8.32M derived: sum of 2 quarters · filed 2020-02-25 | $8.41M derived: sum of 3 quarters · filed 2020-02-25 | $8.41M derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-31 | $140.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $226.00K derived: sum of 2 quarters · filed 2020-02-25 | $229.00K derived: sum of 3 quarters · filed 2020-02-25 | $25.66M 10-K · filed 2020-02-25 |
| 2017-09-30 | $86.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $89.00K derived: sum of 2 quarters · filed 2018-11-06 | $25.52M 10-Q · filed 2018-11-06 | |
| 2017-06-30 | $3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $25.43M 10-Q · filed 2018-08-07 | ||
| 2017-03-31 | $25.43M 10-Q · filed 2018-06-07 | |||
| 2016-12-31 | $12.81M 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |